Nippon Shinyaku Co., Ltd.

BMV:4516 N Stock Report

Market Cap: Mex$25.4b

Nippon Shinyaku Past Earnings Performance

Past criteria checks 5/6

Nippon Shinyaku has been growing earnings at an average annual rate of 8.7%, while the Pharmaceuticals industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 5.9% per year. Nippon Shinyaku's return on equity is 11.7%, and it has net margins of 17.4%.

Key information

8.7%

Earnings growth rate

8.7%

EPS growth rate

Pharmaceuticals Industry Growth12.4%
Revenue growth rate5.9%
Return on equity11.7%
Net Margin17.4%
Next Earnings Update07 Aug 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Nippon Shinyaku makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BMV:4516 N Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24148,25525,85133,95531,676
31 Dec 23146,98424,14034,82228,500
30 Sep 23146,35323,76634,54026,961
30 Jun 23145,56823,31234,09025,308
31 Mar 23144,17522,81233,87224,135
31 Dec 22141,18525,05433,00222,292
30 Sep 22137,05223,64732,26422,549
30 Jun 22131,94620,89431,77823,902
31 Mar 22137,48424,98631,26422,863
31 Dec 21136,26628,22330,78020,351
30 Sep 21135,63629,19030,76518,450
30 Jun 21133,12927,20830,35816,967
31 Mar 21121,88520,70229,31816,104
31 Dec 20120,36120,06528,36714,442
30 Sep 20117,06716,64827,98415,086
30 Jun 20117,15917,75027,52713,861
31 Mar 20116,63716,86627,46713,994
31 Dec 19115,81015,49027,26115,985
30 Sep 19118,60618,55626,59915,404
30 Jun 19116,30917,28926,09516,605
31 Mar 19114,71616,30226,06916,701
31 Dec 18110,76413,99125,61015,897
30 Sep 18105,27911,99225,12414,815
30 Jun 18105,03412,95824,55814,084
31 Mar 18101,44812,95323,76013,221
31 Dec 17100,22410,13424,31916,104
30 Sep 17103,94314,26423,85416,121
30 Jun 1799,25012,63023,56714,584
31 Mar 1798,78111,74923,36714,903
31 Dec 1697,00614,59822,08710,439
30 Sep 1689,3009,30021,64410,066
30 Jun 1688,6928,80921,5749,669
31 Mar 1684,2096,34021,5609,739
31 Dec 1584,7646,55921,3829,394
30 Sep 1582,9345,96521,2799,450
30 Jun 1581,3125,79921,1459,353
31 Mar 1579,9915,88220,9178,968
31 Dec 1479,3946,19120,7209,152
30 Sep 1477,3945,04520,5379,241
30 Jun 1476,8405,26920,1799,413
31 Mar 1476,5175,75019,5469,530
31 Dec 1374,2404,98919,3959,740
30 Sep 1372,3914,69919,1509,463

Quality Earnings: 4516 N has high quality earnings.

Growing Profit Margin: 4516 N's current net profit margins (17.4%) are higher than last year (15.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 4516 N's earnings have grown by 8.7% per year over the past 5 years.

Accelerating Growth: 4516 N's earnings growth over the past year (13.3%) exceeds its 5-year average (8.7% per year).

Earnings vs Industry: 4516 N earnings growth over the past year (13.3%) exceeded the Pharmaceuticals industry 5.9%.

Return on Equity

High ROE: 4516 N's Return on Equity (11.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/10 11:29
End of Day Share Price 2024/04/12 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nippon Shinyaku Co., Ltd. is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tatsuyuki AraiBofA Global Research
Hidemaru YamaguchiCitigroup Global Markets Japan Inc.
Hidemaru YamaguchiCitigroup Inc